- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01679730
Changes of Microbiota in Irritable Bowel Syndrome Patients
March 9, 2015 updated by: Far Eastern Memorial Hospital
To investigate the changes of gastrointestinal microbiota in irritable bowel syndrome patients by hydrogen breath test and molecular-based analysis of microbiota in gastrointestinal tract
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
New Taipei City, Taiwan
- Recruiting
- Far Eastern Memorial Hospital
-
Contact:
- Chen-Shuan Chung, MD, M.Sc
- Email: chugnchenshuan_3@yahoo.com.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Irritable bowel syndrome patients
Description
Inclusion Criteria:
- Case group: 20 to 80 years old irritable bowel syndrome patients
- Control group: 20 to 80 years old healthy subjects
Exclusion Criteria:
- without writtent informed consent
- contraindications for enteroscopy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
irritable bowel syndrome patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
difference in component of microbiota between cases and controls
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Anticipated)
April 1, 2016
Study Registration Dates
First Submitted
August 21, 2012
First Submitted That Met QC Criteria
September 3, 2012
First Posted (Estimate)
September 6, 2012
Study Record Updates
Last Update Posted (Estimate)
March 10, 2015
Last Update Submitted That Met QC Criteria
March 9, 2015
Last Verified
September 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- FEMH-100126-F
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mucosa Associated Bacteria in Small Intestine
-
Mayo ClinicIcahn School of Medicine at Mount Sinai; Imperial College London; University... and other collaboratorsCompletedSmall Intestine BacteriaUnited States
-
NIZO Food ResearchWageningen UniversityCompletedMicrobiota Composition in the Human Small IntestineNetherlands
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompletedthe Local Renin-angiotensin System (RAS) in Small Intestinal Mucosa in ManSweden
-
Region SkaneCounty Council of Halland, Sweden; Probi ABCompletedVentilator-associated Pneumonia | Pathogenic Bacteria in the OropharynxSweden
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
University Hospitals Cleveland Medical CenterCompletedProstatic Diseases | Gastric Foreign Body, Nos | Disorder of Abdomen (Disorder) | Foreign Body in Esophagus | Disease of Small IntestineUnited States
-
University of WashingtonMillennium Pharmaceuticals, Inc.Active, not recruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Small Lymphocytic Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal...United States
-
Turku University HospitalUniversity of TurkuRecruitingInflammatory Bowel Diseases | Crohn Disease | Crohn Colitis | Crohn's Ileocolitis | Crohn Disease in Remission | Crohn Disease of Small IntestineFinland
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneCompletedRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular Lymphoma | Refractory Grade... and other conditionsUnited States